Filing Details
- Accession Number:
- 0000899243-21-008055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-24 17:42:28
- Reporting Period:
- 2021-02-22
- Accepted Time:
- 2021-02-24 17:42:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1797336 | Ayala Pharmaceuticals Inc. | AYLA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647053 | Roni Mamluk | Oppenheimer 4 Rehovot L3 7670104 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-22 | 15,200 | $19.86 | 163,271 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-23 | 7,126 | $17.89 | 156,145 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-24 | 10,800 | $17.40 | 145,345 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
